US 11981921
TIL expansion processes using specific cytokine combinations and/or AKTi treatment
granted A61KA61K35/17A61P
Quick answer
US patent 11981921 (TIL expansion processes using specific cytokine combinations and/or AKTi treatment) held by Iovance Biotherapeutics, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K35/17, A61P, A61P35/00